Preventive Effects of Group Cognitive Behavioral Therapy in First-Year University Students at Risk for Depression: A Non-Randomized Controlled Trial.

depression group cognitive-behavioral therapy harm avoidance prevention temperament and character inventory

Journal

Perceptual and motor skills
ISSN: 1558-688X
Titre abrégé: Percept Mot Skills
Pays: United States
ID NLM: 0401131

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 29 3 2023
pubmed: 1 2 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

High scores on Harm Avoidance (HA) on Cloniger's Temperament and Character Inventory (TCI) have been identified as a risk factor for depression. Group cognitive-behavioral therapy (GCBT) has been found effective in preventing depression and improving depressive symptoms among university students. However, no randomized controlled trials of GCBT have been conducted with university students with high HA. Although we initiated a randomized controlled trial in this study, some participants submitted incomplete questionnaires at baseline interfering with assured randomization; therefore, we report this study as a non-randomized controlled trial. We evaluated whether a GCBT intervention would be effective at reducing HA and, thereby, preventing depression in university students with high HA. We performed final analysis of data on 59 participants in the intervention group and 60 in a control group. We used scores on the Beck Depression Inventory-II (BDI-II) as the primary outcome measure and analysis of covariance to assess group differences on mean BDI-II change scores before the intervention and at six months and one year after the intervention. The intervention group had lower BDI-II scores than the control group at six months after the intervention. GCBT may have facilitated cognitive modification in individuals with high HA, or GCBT may have fostered mutual modeling by group participants. Thus, GCBT may contribute to reducing depressive symptoms in university students with high HA, and associated risk for developing depression.

Identifiants

pubmed: 36720673
doi: 10.1177/00315125231153778
doi:

Types de publication

Randomized Controlled Trial Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

790-807

Auteurs

Sayaka Ogawa (S)

Health Center, 12961Nagasaki University, Nagasaki, Japan.

Masaki Hayashida (M)

Health Center, 12961Nagasaki University, Nagasaki, Japan.

Jun Tayama (J)

68397Faculty of Human Sciences Waseda University, Tokorozawa, Japan.

Tatsuo Saigo (T)

Graduate School of Psychological Science, 12811Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Naoki Nakaya (N)

Tohoku Medical Megabank Organization, 13101Tohoku University, Sendai Aoba-ku, Japan.

Toshimasa Sone (T)

Department of Occupational Therapy, 183174Fukushima Medical University School of Health Sciences, Fukushima, Japan.

Masakazu Kobayashi (M)

Health Center, 12961Nagasaki University, Nagasaki, Japan.

Peter Bernick (P)

Health Center, 12961Nagasaki University, Nagasaki, Japan.
Student Accessibility Office, 12961Nagasaki University, Nagasaki, Japan.

Atsushi Takeoka (A)

Health Center, 12961Nagasaki University, Nagasaki, Japan.

Susumu Shirabe (S)

National Research Center for the Control and Prevention of Infectious Diseases, 12961Nagasaki University, Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH